Downregulation of MIF in ovarian cancer cells led to a decrease in the production of cytokines important in TAM recruitment such as CCL2 and CCL22 in vitro and an increase in survival and decrease in ascites in vivo (51). The gene discussed is MIF; the disease is ovarian cancer.